These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33154480)

  • 1. Non-classical crystallisation pathway directly observed for a pharmaceutical crystal via liquid phase electron microscopy.
    Cookman J; Hamilton V; Hall SR; Bangert U
    Sci Rep; 2020 Nov; 10(1):19156. PubMed ID: 33154480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualising early-stage liquid phase organic crystal growth via liquid cell electron microscopy.
    Cookman J; Hamilton V; Price LS; Hall SR; Bangert U
    Nanoscale; 2020 Feb; 12(7):4636-4644. PubMed ID: 32044911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal quality and physical reactivity in the case of flufenamic acid (FFA).
    Li H; Wen H; Stowell JG; Morris KR; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):3839-48. PubMed ID: 20589945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions.
    Guo M; Wang K; Hamill N; Lorimer K; Li M
    Mol Pharm; 2016 Sep; 13(9):3292-307. PubMed ID: 27494289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution.
    Guo M; Wang K; Qiao N; Fábián L; Sadiq G; Li M
    Mol Pharm; 2017 Dec; 14(12):4583-4596. PubMed ID: 29091446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Imaging of the Kinetic Crystallization Pathway: Simulation and Liquid-Phase Transmission Electron Microscopy Observations.
    Xu Z; Ou Z
    Materials (Basel); 2023 Mar; 16(5):. PubMed ID: 36903141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?
    Lee EH; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):4013-22. PubMed ID: 20589947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleation of crystals from solution: classical and two-step models.
    Erdemir D; Lee AY; Myerson AS
    Acc Chem Res; 2009 May; 42(5):621-9. PubMed ID: 19402623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive-induced metastable single crystal of mefenamic acid.
    Lee EH; Byrn SR; Carvajal MT
    Pharm Res; 2006 Oct; 23(10):2375-80. PubMed ID: 16927183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal.
    Nechipadappu SK; Tekuri V; Trivedi DR
    J Pharm Sci; 2017 May; 106(5):1384-1390. PubMed ID: 28185907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal anisotropy explains structure-mechanics impact on tableting performance of flufenamic acid polymorphs.
    Jain A; Shah HS; Johnson PR; Narang AS; Morris KR; Haware RV
    Eur J Pharm Biopharm; 2018 Nov; 132():83-92. PubMed ID: 30213565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-nucleation clusters as solute precursors in crystallisation.
    Gebauer D; Kellermeier M; Gale JD; Bergström L; Cölfen H
    Chem Soc Rev; 2014 Apr; 43(7):2348-71. PubMed ID: 24457316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Metastable Precursors of Ibuprofen as Aqueous Nucleation Intermediates.
    Wiedenbeck E; Kovermann M; Gebauer D; Cölfen H
    Angew Chem Int Ed Engl; 2019 Dec; 58(52):19103-19109. PubMed ID: 31556970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.
    López-Mejías V; Kampf JW; Matzger AJ
    J Am Chem Soc; 2012 Jun; 134(24):9872-5. PubMed ID: 22690822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multistep Crystallization of Pharmaceutical Amorphous Nanoparticles via a Cognate Pathway of Oriented Attachment: Direct Evidence of Nonclassical Crystallization for Organic Molecules.
    Chen Z; Higashi K; Ueda K; Moribe K
    Nano Lett; 2022 Aug; 22(16):6841-6846. PubMed ID: 35830610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoscale Clusters in the Crystallisation of Organic Molecules.
    Barua H; Svärd M; Rasmuson ÅC; Hudson SP; Cookman J
    Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202312100. PubMed ID: 38055699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-step nucleation of metal-organic framework nanocrystals.
    Liu X; Chee SW; Raj S; Sawczyk M; Král P; Mirsaidov U
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple pathways in NaCl homogeneous crystal nucleation.
    Finney AR; Salvalaglio M
    Faraday Discuss; 2022 Jul; 235(0):56-80. PubMed ID: 35438090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution imaging of organic pharmaceutical crystals by transmission electron microscopy and scanning moiré fringes.
    S'ari M; Koniuch N; Brydson R; Hondow N; Brown A
    J Microsc; 2020 Sep; 279(3):197-206. PubMed ID: 31985063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism of ferritin crystallization revealed by cryo-STEM tomography.
    Houben L; Weissman H; Wolf SG; Rybtchinski B
    Nature; 2020 Mar; 579(7800):540-543. PubMed ID: 32214264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.